EAM
Empirical Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Sell |
3,386
-40
| -1% | -$7.43K | 0.19% | 162 |
|
|
2025
Q1 | $718K | Sell |
3,426
-222,837
| -98% | -$46.7M | 0.24% | 120 |
|
|
2024
Q4 | $741K | Buy |
226,263
+192,734
| +575% | +$631K | 0.25% | 115 |
|
|
2024
Q3 | $607K | Sell |
33,529
-397
| -1% | -$7.19K | 0.22% | 141 |
|
|
2024
Q2 | $600K | Buy |
33,926
+27,131
| +399% | +$480K | 0.23% | 127 |
|
|
2024
Q1 | $434K | Buy |
6,795
+4,264
| +168% | +$272K | 0.21% | 129 |
|
|
2023
Q4 | $392K | Buy |
2,531
+120
| +5% | +$18.6K | 0.32% | 111 |
|
|
2023
Q3 | $359K | Buy |
2,411
+54
| +2% | +$8.05K | 0.31% | 110 |
|
|
2023
Q2 | $318K | Sell |
2,357
-1
| -0% | -$135 | 0.28% | 110 |
|
|
2023
Q1 | $376K | Sell |
2,358
-337
| -13% | -$53.7K | 0.36% | 98 |
|
|
2022
Q4 | $381K | Buy |
2,695
+334
| +14% | +$47.2K | 0.4% | 98 |
|
|
2022
Q3 | $317K | Sell |
2,361
-3
| -0.1% | -$403 | 0.35% | 107 |
|
|
2022
Q2 | $362K | Buy |
2,364
+19
| +0.8% | +$2.91K | 0.38% | 100 |
|
|
2022
Q1 | $380K | Buy |
+2,345
| New | +$380K | 0.36% | 97 |
|